Literature DB >> 21663528

Factors connected with the female sex seem to play an important role in differentiated thyroid cancer.

Elwira Przybylik-Mazurek1, Alicja Hubalewska-Dydejczyk, Anna Fedorowicz, Dorota Pach.   

Abstract

AIM: The aim of the study was to analyze whether female sex hormones and other factors connected with the female sex could increase the risk of differentiated thyroid cancer (DTC).
MATERIAL AND METHODS: Ninety-nine patients with a mean age±SD of 40.5±5.9 years with DTC and 51 healthy women with a mean age of 36.52±8.3 years were examined. Gynecological and obstetric histories were taken and serum estradiol and progesterone levels were analyzed in all women.
RESULTS: Patients with DTC had more frequent menstrual cycle disturbances, used hormone-containing medicines more frequently, were mulitiparous more frequently, had spontaneous miscarriages more frequently, and their duration of lactation was significantly shorter than in controls. The mean serum estradiol level±SD in women with DTC was significantly higher than in the controls, in the follicular phase 193.74±66.31 vs. 157.63±42.88 pmol/l and in the luteal phase 519±176.9 vs. 369±71.49 pmol/l. The mean serum progesterone level±SD was higher in the controls than in patients with DTC, in the follicular phase: 2.11±0.70 vs. 1.38±0.56 nmol/l and in the luteal phase 20.95±17.46 vs. 17.31±12.28 nmol/l.
CONCLUSIONS: The results of these studies imply that estrogens may at least modify the proliferation of thyroid cancer cells. The sex hormones probably intensify the actions of other carcinogens as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663528     DOI: 10.3109/09513590.2011.563909

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  Papillary thyroid carcinoma risk factors in the Yunnan plateau of southwestern China.

Authors:  Rong Zeng; Tao Shou; Kun-Xian Yang; Tao Shen; Jin-Ping Zhang; Rong-Xia Zuo; Yong-Qing Zheng; Xin-Ming Yan
Journal:  Ther Clin Risk Manag       Date:  2016-06-30       Impact factor: 2.423

2.  Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.

Authors:  Yu-Jie Dai; Yi-Bo Qiu; Rong Jiang; Man Xu; Ling-Yao Liao; George G Chen; Zhi-Min Liu
Journal:  Cell Oncol (Dordr)       Date:  2018-01-24       Impact factor: 6.730

3.  Breastfeeding and thyroid cancer risk in women: A dose-response meta-analysis of epidemiological studies.

Authors:  Xingyang Yi; Jingjing Zhu; Xiao Zhu; Guang Jian Liu; Lang Wu
Journal:  Clin Nutr       Date:  2015-12-17       Impact factor: 7.324

4.  Parity and thyroid cancer risk: a meta-analysis of epidemiological studies.

Authors:  Jingjing Zhu; Xiao Zhu; Chao Tu; Yuan-Yuan Li; Ke-Qing Qian; Cheng Jiang; Tong-Bao Feng; Changwei Li; Guang Jian Liu; Lang Wu
Journal:  Cancer Med       Date:  2015-12-29       Impact factor: 4.452

5.  Concomitant high expression of ERα36, EGFR and HER2 is associated with aggressive behaviors of papillary thyroid carcinomas.

Authors:  Yu-Jie Dai; Yi-Bo Qiu; Rong Jiang; Man Xu; Le Zhao; George G Chen; Zhi-Min Liu
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

Review 6.  Fertility Drugs Associated with Thyroid Cancer Risk: A Systematic Review and Meta-Analysis.

Authors:  QingAn Yu; XiaoYing Lv; KunPeng Liu; DaKun Ma; YaoHua Wu; WenJie Dai; HongChi Jiang
Journal:  Biomed Res Int       Date:  2018-05-10       Impact factor: 3.411

Review 7.  A Role for Estrogen Receptor alpha36 in Cancer Progression.

Authors:  Maria Teresa Pagano; Elena Ortona; Maria Luisa Dupuis
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

8.  PES1 promotes the occurrence and development of papillary thyroid cancer by upregulating the ERα/ERβ protein ratio.

Authors:  Yi-Bo Qiu; Ling-Yao Liao; Rong Jiang; Man Xu; Lin-Wan Xu; George G Chen; Zhi-Min Liu
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.